West Pharmaceutical Services, Inc.
US ˙ NYSE ˙ US9553061055

SecurityWST / West Pharmaceutical Services, Inc.
InstitutionPrivate Advisor Group, LLC
Latest Disclosed Ownership827 shares
Latest Disclosed Value $ 207,280
Private Advisor Group, LLC reports 37.01% decrease in ownership of WST / West Pharmaceutical Services, Inc.

On April 24, 2026 - Private Advisor Group, LLC filed a 13F-HR form disclosing ownership of 827 shares of West Pharmaceutical Services, Inc. (US:WST) valued at $207,279 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,313 shares of West Pharmaceutical Services, Inc.. This represents a change in shares of -37.01% during the quarter. The current value of the position is $261,588 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 827 -486 -37.01 207 -42.66 0.0009
2026-02-17 2025-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,313 -58 -4.23 361 0.56 0.0017
2025-11-13 2025-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,371 1,371 360 0.0018
2025-05-05 2025-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -1,301 -100.00 0 -100.00
2025-02-03 2024-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,301 -358 -21.58 426 -14.29 0.0024
2024-10-22 2024-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,659 -172 -9.39 498 -17.58 0.0031
2024-08-05 2024-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,831 208 12.82 603 -6.07 0.0040
2024-04-30 2024-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,623 -11 -0.67 642 11.65 0.0046
2024-02-06 2023-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,634 230 16.38 575 9.32 0.0045
2023-11-03 2023-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,404 -75 -5.07 527 -4.88 0.0047
2023-08-10 2023-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,479 -25 -1.66 553 6.14 0.0048
2023-05-10 2023-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,504 -353 -19.01 521 76.61 0.0050
2023-01-18 2022-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,857 -118 -5.97 295 -39.30 0.0149
2022-10-14 2022-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,975 -1,501 -43.18 486 -53.76 0.0056
2022-07-13 2022-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,476 31 0.90 1,051 -25.78 0.0094
2022-05-12 2022-03-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 3,445 -107 -3.01 1,416 -15.01 0.0108
2022-05-10 2022-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,552 0 1,666 0.0125
2022-02-10 2021-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,552 -1,932 -35.23 1,666 -28.44 0.0125
2021-10-14 2021-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,484 3,475 172.97 2,328 222.88 0.0148
2021-08-12 2021-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,009 884 78.58 721 127.44 0.0063
2021-04-22 2021-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,125 -521 -31.65 317 -32.12 0.0030
2021-04-01 2020-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,646 1,646 467 0.0049
2020-10-30 2020-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -504 -100.00 0 -100.00
2020-08-17 2020-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 504 504 114 0.0016
2020-05-12 2020-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -2,867 -100.00 0 -100.00
2020-02-10 2019-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,867 97 3.50 431 9.67 0.0067
2019-11-13 2019-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,770 2,770 393 0.0061
2019-08-14 2019-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -3,083 -100.00 0 -100.00
2019-05-13 2019-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,083 3,083 340 0.0067
2019-02-08 2018-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -2,598 -100.00 0 -100.00
2018-11-01 2018-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,598 -480 -15.59 321 5.59 0.0066
2018-08-09 2018-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,078 3,078 304 0.0050
2018-05-09 2018-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -2,176 -100.00 0 -100.00
2018-02-07 2017-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,176 24 1.12 221 9.41 0.0093
2017-11-13 2017-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,152 2,152 202 0.0050
2017-08-10 2017-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -2,899 -100.00 0 -100.00
2017-05-10 2017-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,899 91 3.24 232 -3.73 0.0065
2017-02-09 2016-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,808 2,808 241 0.0079
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.